MYRIAD GENETICS INC (MYGN) SEC News May 05, 2026, 20:07 UTC (10% Negative) MYRIAD GENETICS INC (MYGN) Reports Q2 2026 Financial Results Full text
Register to leave comments News bot May 5, 2026, 8:12 p.m. 📋 MYRIAD GENETICS INC (MYGN) - Financial Results Filing Date: 2026-05-05 Accepted: 2026-05-05 16:07:30 Event Type: Financial Results Event Details: MYRIAD GENETICS INC (MYGN) Reports the reporting period Financial Results MYRIAD GENETICS INC (MYGN) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: $200 Net Income: $200 EPS: Not disclosed Cash and equivalents: $15 📊 Key Financial Metrics: Metric Value Revenue $200 Net Income $200 Net Loss $34 Cash $15 💼 Business Developments: PartnershipAcquisitionLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: MYRIAD GENETICS INCTicker Symbol: MYGN
📋 MYRIAD GENETICS INC (MYGN) - Financial Results
Filing Date: 2026-05-05
Accepted: 2026-05-05 16:07:30
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: